COVID-19 Emerging themes: T-cell immune responses & immunoSEQ® T-MAP™ COVID applications


Thomas Snyder

PhD, VP, Research, T-Detect, Adaptive Biotechnologies

Paul Fields

PhD, Manager, Computational Biology, Adaptive Biotechnologies

At the beginning of 2020, few would have predicted that a global pandemic would turn our daily lives upside down. But 1 year later, the research community may have a clearer view of what might lie ahead. Throughout 2020, Adaptive Biotechnologies, along with researchers and collaborators around the world, contributed to the massive effort to understand and fight the COVID-19 pandemic. This webinar focuses on what we have learned so far, and where COVID-19 research is headed in 2021.

In this webinar, you will find out more about:

  • new data and the clinical utility of signals, including disease severity, neutralizing antibody response, and data on vaccine vs. viral response;
  • the new immunoSEQ® T-MAP™ COVID feature, called the Classifier, how it was developed, what this feature can tell you, and how can it be used to propel your COVID-19 research;
  • the current and future research applications of the immunoSEQ T-MAP COVID tool;
  • future research directions and implications of the T-cell immune response for fighting emerging SARS-CoV-2 variants.

For Research Use Only. Not for use in diagnostic procedures.

All emails contain an unsubscribe link.You can review our privacy policy, cookie policy and terms and conditions online.